Recent studies have indicated a potential correlation between the development of sarcopenia and specific genetic polymorphisms in the methylenetetrahydrofolate reductase (MTHFR), alpha-actinin-3 (ACTN3), and nuclear respiratory factor 2 (NRF2) genes. The gene discussed is ACTN3; the disease is sarcopenia.